Loading…

Composition and inhibitory properties of endogenous urinary GAGS are different in subjects from two race groups with different occurrence rates of kidney stones: Pilot studies provide unique evidence in support of an inhibitory role for this group of compounds

•Inter-race comparison of concentration and composition of endogenous GAGS: 1st study.•Inter-race comparison of urinary crystal inhibition by endogenous GAGs: 1st study.•Concentration of chondroitin sulfate in GAGS: black subjects (B) > white subjects (W).•Inhibitory effect on calcium oxalate cry...

Full description

Saved in:
Bibliographic Details
Published in:Clinica chimica acta 2022-01, Vol.525, p.84-90
Main Authors: Jappie, Dalielah, Rodgers, Allen, Ravenscroft, Neil, Webber, Dawn, Gohel, Mayur Danny I.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c353t-3c9aa4654d7717f9e94f943ce9b23f47a5c6945acf388f53066e5c2e7b3cffd33
cites cdi_FETCH-LOGICAL-c353t-3c9aa4654d7717f9e94f943ce9b23f47a5c6945acf388f53066e5c2e7b3cffd33
container_end_page 90
container_issue
container_start_page 84
container_title Clinica chimica acta
container_volume 525
creator Jappie, Dalielah
Rodgers, Allen
Ravenscroft, Neil
Webber, Dawn
Gohel, Mayur Danny I.
description •Inter-race comparison of concentration and composition of endogenous GAGS: 1st study.•Inter-race comparison of urinary crystal inhibition by endogenous GAGs: 1st study.•Concentration of chondroitin sulfate in GAGS: black subjects (B) > white subjects (W).•Inhibitory effect on calcium oxalate crystallization: GAGS from B > GAGS from W.•Stronger inhibitory effect attributed to higher chondroitin sulfate in GAGS from B. Calcium oxalate (CaOx) kidney stone disease is common in South African whites (W) but is rare in the black population (B). The possible role of endogenous urinary glycosaminoglycans (GAGs) has not been previously investigated in this context. To determine concentration, composition, structure and CaOx crystal-inhibiting properties of this group of compounds in ultrafiltered urine of healthy subjects from both groups. GAGS were isolated from 24 h urine samples and were quantified and characterized by sequential precipitation, Bradford protein assay, high performance liquid chromatography, and anion exchange high performance chromatography. CaOx crystal inhibition was determined in ultrafiltered urinary fractions to which purified GAGS (PG) from each group (PGB and PGW) had been added. Nucleation, growth and aggregation were measured by Coulter particle counting, spectrophotometric assay and [14C]-oxalate deposition. Higher concentrations of chondroitin sulfate (CS) were found in PGB than in PGW. PGB inhibited crystallization to a greater extent than PGW. We attribute the stronger inhibitory effect of PGB to its higher content of CS and suggest that the superior inhibition of CaOx crystallization by PGB relative to PGW might be a contributory factor in accounting for the lower stone occurrence rate in B.
doi_str_mv 10.1016/j.cca.2021.11.030
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2612773006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009898121004216</els_id><sourcerecordid>2612773006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-3c9aa4654d7717f9e94f943ce9b23f47a5c6945acf388f53066e5c2e7b3cffd33</originalsourceid><addsrcrecordid>eNp9UU1v1DAUDKiILoUfwAW9Yy8JdpxPOFUrWJAqgQScLcd-7npJ7GA7rfrvcUhBPXGynzwznnmTZa8pKSihzdtTIaUoSlLSgtKCMPI029GuZTmr-vIs2xFC-rzrO3qevQjhlMaKNPR5dp7eGSOk3D0527tpdsFE4ywIq8DYoxlMdP4eZu9m9NFgAKcBrXI3aN0SYPHGigQ4XB2-gfAIymiNHm1MdAjLcEIZA2jvJoh3DryQCDfeLXOAOxOPj_BOysWnWwJ4Ebeffhpl8R5CdBbDO_hqRhfTtKjVSTJ1axTCYs2vBQHXYWX_-XienY-rhLCPg3g3ImjnIR5N2IysILlGX6wKL7NnWowBXz2cF9mPjx--7z_l118On_dX17lkNYs5k70QVVNXqm1pq3vsK91XTGI_lExXrahl01e1kJp1na4ZaRqsZYntwKTWirGL7HLTTSGS-RD5ZILEcRQW01552dCybVMxTYLSDSq9C8Gj5rM3U1o6p4Sv5fMTT-XztXxOKU_lJ86bB_llmFD9Y_xtOwHebwBMIW8Neh6kWbenjE-NceXMf-R_AyeuxuQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2612773006</pqid></control><display><type>article</type><title>Composition and inhibitory properties of endogenous urinary GAGS are different in subjects from two race groups with different occurrence rates of kidney stones: Pilot studies provide unique evidence in support of an inhibitory role for this group of compounds</title><source>Elsevier</source><creator>Jappie, Dalielah ; Rodgers, Allen ; Ravenscroft, Neil ; Webber, Dawn ; Gohel, Mayur Danny I.</creator><creatorcontrib>Jappie, Dalielah ; Rodgers, Allen ; Ravenscroft, Neil ; Webber, Dawn ; Gohel, Mayur Danny I.</creatorcontrib><description>•Inter-race comparison of concentration and composition of endogenous GAGS: 1st study.•Inter-race comparison of urinary crystal inhibition by endogenous GAGs: 1st study.•Concentration of chondroitin sulfate in GAGS: black subjects (B) &gt; white subjects (W).•Inhibitory effect on calcium oxalate crystallization: GAGS from B &gt; GAGS from W.•Stronger inhibitory effect attributed to higher chondroitin sulfate in GAGS from B. Calcium oxalate (CaOx) kidney stone disease is common in South African whites (W) but is rare in the black population (B). The possible role of endogenous urinary glycosaminoglycans (GAGs) has not been previously investigated in this context. To determine concentration, composition, structure and CaOx crystal-inhibiting properties of this group of compounds in ultrafiltered urine of healthy subjects from both groups. GAGS were isolated from 24 h urine samples and were quantified and characterized by sequential precipitation, Bradford protein assay, high performance liquid chromatography, and anion exchange high performance chromatography. CaOx crystal inhibition was determined in ultrafiltered urinary fractions to which purified GAGS (PG) from each group (PGB and PGW) had been added. Nucleation, growth and aggregation were measured by Coulter particle counting, spectrophotometric assay and [14C]-oxalate deposition. Higher concentrations of chondroitin sulfate (CS) were found in PGB than in PGW. PGB inhibited crystallization to a greater extent than PGW. We attribute the stronger inhibitory effect of PGB to its higher content of CS and suggest that the superior inhibition of CaOx crystallization by PGB relative to PGW might be a contributory factor in accounting for the lower stone occurrence rate in B.</description><identifier>ISSN: 0009-8981</identifier><identifier>EISSN: 1873-3492</identifier><identifier>DOI: 10.1016/j.cca.2021.11.030</identifier><identifier>PMID: 34933002</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Calcium Oxalate ; Crystallization ; Crystallization inhibitors ; Glycosaminoglycans ; Humans ; Inter-race differences ; Kidney Calculi ; Kidney stones ; Pilot Projects ; Urinary Calculi ; Urinary glycosaminoglycans</subject><ispartof>Clinica chimica acta, 2022-01, Vol.525, p.84-90</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-3c9aa4654d7717f9e94f943ce9b23f47a5c6945acf388f53066e5c2e7b3cffd33</citedby><cites>FETCH-LOGICAL-c353t-3c9aa4654d7717f9e94f943ce9b23f47a5c6945acf388f53066e5c2e7b3cffd33</cites><orcidid>0000-0002-8877-4646 ; 0000-0001-8476-5630</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34933002$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jappie, Dalielah</creatorcontrib><creatorcontrib>Rodgers, Allen</creatorcontrib><creatorcontrib>Ravenscroft, Neil</creatorcontrib><creatorcontrib>Webber, Dawn</creatorcontrib><creatorcontrib>Gohel, Mayur Danny I.</creatorcontrib><title>Composition and inhibitory properties of endogenous urinary GAGS are different in subjects from two race groups with different occurrence rates of kidney stones: Pilot studies provide unique evidence in support of an inhibitory role for this group of compounds</title><title>Clinica chimica acta</title><addtitle>Clin Chim Acta</addtitle><description>•Inter-race comparison of concentration and composition of endogenous GAGS: 1st study.•Inter-race comparison of urinary crystal inhibition by endogenous GAGs: 1st study.•Concentration of chondroitin sulfate in GAGS: black subjects (B) &gt; white subjects (W).•Inhibitory effect on calcium oxalate crystallization: GAGS from B &gt; GAGS from W.•Stronger inhibitory effect attributed to higher chondroitin sulfate in GAGS from B. Calcium oxalate (CaOx) kidney stone disease is common in South African whites (W) but is rare in the black population (B). The possible role of endogenous urinary glycosaminoglycans (GAGs) has not been previously investigated in this context. To determine concentration, composition, structure and CaOx crystal-inhibiting properties of this group of compounds in ultrafiltered urine of healthy subjects from both groups. GAGS were isolated from 24 h urine samples and were quantified and characterized by sequential precipitation, Bradford protein assay, high performance liquid chromatography, and anion exchange high performance chromatography. CaOx crystal inhibition was determined in ultrafiltered urinary fractions to which purified GAGS (PG) from each group (PGB and PGW) had been added. Nucleation, growth and aggregation were measured by Coulter particle counting, spectrophotometric assay and [14C]-oxalate deposition. Higher concentrations of chondroitin sulfate (CS) were found in PGB than in PGW. PGB inhibited crystallization to a greater extent than PGW. We attribute the stronger inhibitory effect of PGB to its higher content of CS and suggest that the superior inhibition of CaOx crystallization by PGB relative to PGW might be a contributory factor in accounting for the lower stone occurrence rate in B.</description><subject>Calcium Oxalate</subject><subject>Crystallization</subject><subject>Crystallization inhibitors</subject><subject>Glycosaminoglycans</subject><subject>Humans</subject><subject>Inter-race differences</subject><subject>Kidney Calculi</subject><subject>Kidney stones</subject><subject>Pilot Projects</subject><subject>Urinary Calculi</subject><subject>Urinary glycosaminoglycans</subject><issn>0009-8981</issn><issn>1873-3492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9UU1v1DAUDKiILoUfwAW9Yy8JdpxPOFUrWJAqgQScLcd-7npJ7GA7rfrvcUhBPXGynzwznnmTZa8pKSihzdtTIaUoSlLSgtKCMPI029GuZTmr-vIs2xFC-rzrO3qevQjhlMaKNPR5dp7eGSOk3D0527tpdsFE4ywIq8DYoxlMdP4eZu9m9NFgAKcBrXI3aN0SYPHGigQ4XB2-gfAIymiNHm1MdAjLcEIZA2jvJoh3DryQCDfeLXOAOxOPj_BOysWnWwJ4Ebeffhpl8R5CdBbDO_hqRhfTtKjVSTJ1axTCYs2vBQHXYWX_-XienY-rhLCPg3g3ImjnIR5N2IysILlGX6wKL7NnWowBXz2cF9mPjx--7z_l118On_dX17lkNYs5k70QVVNXqm1pq3vsK91XTGI_lExXrahl01e1kJp1na4ZaRqsZYntwKTWirGL7HLTTSGS-RD5ZILEcRQW01552dCybVMxTYLSDSq9C8Gj5rM3U1o6p4Sv5fMTT-XztXxOKU_lJ86bB_llmFD9Y_xtOwHebwBMIW8Neh6kWbenjE-NceXMf-R_AyeuxuQ</recordid><startdate>20220115</startdate><enddate>20220115</enddate><creator>Jappie, Dalielah</creator><creator>Rodgers, Allen</creator><creator>Ravenscroft, Neil</creator><creator>Webber, Dawn</creator><creator>Gohel, Mayur Danny I.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8877-4646</orcidid><orcidid>https://orcid.org/0000-0001-8476-5630</orcidid></search><sort><creationdate>20220115</creationdate><title>Composition and inhibitory properties of endogenous urinary GAGS are different in subjects from two race groups with different occurrence rates of kidney stones: Pilot studies provide unique evidence in support of an inhibitory role for this group of compounds</title><author>Jappie, Dalielah ; Rodgers, Allen ; Ravenscroft, Neil ; Webber, Dawn ; Gohel, Mayur Danny I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-3c9aa4654d7717f9e94f943ce9b23f47a5c6945acf388f53066e5c2e7b3cffd33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Calcium Oxalate</topic><topic>Crystallization</topic><topic>Crystallization inhibitors</topic><topic>Glycosaminoglycans</topic><topic>Humans</topic><topic>Inter-race differences</topic><topic>Kidney Calculi</topic><topic>Kidney stones</topic><topic>Pilot Projects</topic><topic>Urinary Calculi</topic><topic>Urinary glycosaminoglycans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jappie, Dalielah</creatorcontrib><creatorcontrib>Rodgers, Allen</creatorcontrib><creatorcontrib>Ravenscroft, Neil</creatorcontrib><creatorcontrib>Webber, Dawn</creatorcontrib><creatorcontrib>Gohel, Mayur Danny I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinica chimica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jappie, Dalielah</au><au>Rodgers, Allen</au><au>Ravenscroft, Neil</au><au>Webber, Dawn</au><au>Gohel, Mayur Danny I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Composition and inhibitory properties of endogenous urinary GAGS are different in subjects from two race groups with different occurrence rates of kidney stones: Pilot studies provide unique evidence in support of an inhibitory role for this group of compounds</atitle><jtitle>Clinica chimica acta</jtitle><addtitle>Clin Chim Acta</addtitle><date>2022-01-15</date><risdate>2022</risdate><volume>525</volume><spage>84</spage><epage>90</epage><pages>84-90</pages><issn>0009-8981</issn><eissn>1873-3492</eissn><abstract>•Inter-race comparison of concentration and composition of endogenous GAGS: 1st study.•Inter-race comparison of urinary crystal inhibition by endogenous GAGs: 1st study.•Concentration of chondroitin sulfate in GAGS: black subjects (B) &gt; white subjects (W).•Inhibitory effect on calcium oxalate crystallization: GAGS from B &gt; GAGS from W.•Stronger inhibitory effect attributed to higher chondroitin sulfate in GAGS from B. Calcium oxalate (CaOx) kidney stone disease is common in South African whites (W) but is rare in the black population (B). The possible role of endogenous urinary glycosaminoglycans (GAGs) has not been previously investigated in this context. To determine concentration, composition, structure and CaOx crystal-inhibiting properties of this group of compounds in ultrafiltered urine of healthy subjects from both groups. GAGS were isolated from 24 h urine samples and were quantified and characterized by sequential precipitation, Bradford protein assay, high performance liquid chromatography, and anion exchange high performance chromatography. CaOx crystal inhibition was determined in ultrafiltered urinary fractions to which purified GAGS (PG) from each group (PGB and PGW) had been added. Nucleation, growth and aggregation were measured by Coulter particle counting, spectrophotometric assay and [14C]-oxalate deposition. Higher concentrations of chondroitin sulfate (CS) were found in PGB than in PGW. PGB inhibited crystallization to a greater extent than PGW. We attribute the stronger inhibitory effect of PGB to its higher content of CS and suggest that the superior inhibition of CaOx crystallization by PGB relative to PGW might be a contributory factor in accounting for the lower stone occurrence rate in B.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34933002</pmid><doi>10.1016/j.cca.2021.11.030</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-8877-4646</orcidid><orcidid>https://orcid.org/0000-0001-8476-5630</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0009-8981
ispartof Clinica chimica acta, 2022-01, Vol.525, p.84-90
issn 0009-8981
1873-3492
language eng
recordid cdi_proquest_miscellaneous_2612773006
source Elsevier
subjects Calcium Oxalate
Crystallization
Crystallization inhibitors
Glycosaminoglycans
Humans
Inter-race differences
Kidney Calculi
Kidney stones
Pilot Projects
Urinary Calculi
Urinary glycosaminoglycans
title Composition and inhibitory properties of endogenous urinary GAGS are different in subjects from two race groups with different occurrence rates of kidney stones: Pilot studies provide unique evidence in support of an inhibitory role for this group of compounds
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T16%3A16%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Composition%20and%20inhibitory%20properties%20of%20endogenous%20urinary%20GAGS%20are%20different%20in%20subjects%20from%20two%20race%20groups%20with%20different%20occurrence%20rates%20of%20kidney%20stones:%20Pilot%20studies%20provide%20unique%20evidence%20in%20support%20of%20an%20inhibitory%20role%20for%20this%20group%20of%20compounds&rft.jtitle=Clinica%20chimica%20acta&rft.au=Jappie,%20Dalielah&rft.date=2022-01-15&rft.volume=525&rft.spage=84&rft.epage=90&rft.pages=84-90&rft.issn=0009-8981&rft.eissn=1873-3492&rft_id=info:doi/10.1016/j.cca.2021.11.030&rft_dat=%3Cproquest_cross%3E2612773006%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-3c9aa4654d7717f9e94f943ce9b23f47a5c6945acf388f53066e5c2e7b3cffd33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2612773006&rft_id=info:pmid/34933002&rfr_iscdi=true